43 related articles for article (PubMed ID: 6580493)
1. A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia.
Meyskens FL; Graham V; Chvapil M; Dorr RT; Alberts DS; Surwit EA
J Natl Cancer Inst; 1983 Nov; 71(5):921-5. PubMed ID: 6580493
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.
Graham V; Surwit ES; Weiner S; Meyskens FL
West J Med; 1986 Aug; 145(2):192-5. PubMed ID: 3765597
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions.
Surwit EA; Graham V; Droegemueller W; Alberts D; Chvapil M; Dorr RT; Davis JR; Meyskens FL
Am J Obstet Gynecol; 1982 Aug; 143(7):821-3. PubMed ID: 7048932
[TBL] [Abstract][Full Text] [Related]
4. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia.
Peng YM; Alberts DS; Graham V; Surwit EA; Weiner S; Meyskens FL
Invest New Drugs; 1986; 4(3):245-9. PubMed ID: 3818229
[TBL] [Abstract][Full Text] [Related]
5. Cervical intraepithelial neoplasia associated with exposure to diethylstilbestrol in utero: a clinical and pathologic study.
Orr JW; Shingleton HM; Gore H; Austin JM; Hatch KD; Soong SJ
Obstet Gynecol; 1981 Jul; 58(1):75-82. PubMed ID: 7195532
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
[TBL] [Abstract][Full Text] [Related]
7. Cytology and colposcopy in the diagnosis and management of outpatients with cervical intraepithelial neoplasia.
Allahverdian V; Valaitis J; Kalis O; Pearlman S
J Reprod Med; 1980 Jan; 24(1):1-4. PubMed ID: 7359496
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention trials in the cervix: design, feasibility, and recruitment.
Mitchell MF; Hittelman WN; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Hong WK
J Cell Biochem Suppl; 1995; 23():104-12. PubMed ID: 8747384
[TBL] [Abstract][Full Text] [Related]
9. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
Dhaubhadel P; Vaidya A; Choudhary P
JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
[TBL] [Abstract][Full Text] [Related]
10. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
[TBL] [Abstract][Full Text] [Related]
11. Abnormal cervical cytology in pregnancy: a 17-year experience.
Economos K; Perez Veridiano N; Delke I; Collado ML; Tancer ML
Obstet Gynecol; 1993 Jun; 81(6):915-8. PubMed ID: 8497355
[TBL] [Abstract][Full Text] [Related]
12. The role of colposcopy in the management of cervical intraepithelial neoplasia during pregnancy and postpartum.
Kohan S; Beckman EM; Bigelow B; Klein SA; Douglas GW
J Reprod Med; 1980 Nov; 25(5):279-84. PubMed ID: 7452638
[TBL] [Abstract][Full Text] [Related]
13. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
[TBL] [Abstract][Full Text] [Related]
14. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy.
Weiner SA; Surwit EA; Graham VE; Meyskens FL
Invest New Drugs; 1986; 4(3):241-4. PubMed ID: 3818228
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of cervix cancer: Phase I-II: A feasibility study involving the topical vaginal administration of retinyl acetate gel.
Romney SL; Dwyer A; Slagle S; Duttagupta C; Palan PR; Basu J; Calderin S; Kadish A
Gynecol Oncol; 1985 Jan; 20(1):109-19. PubMed ID: 3965373
[TBL] [Abstract][Full Text] [Related]
16. Viruses, the vaginitis-cervicitis complex and cervical cancer in man.
Di Virgilio G; Lavenda N; Siegel D
Am J Obstet Gynecol; 1965 Oct; 93(4):491-501. PubMed ID: 5841728
[No Abstract] [Full Text] [Related]
17. Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine.
Ferreira R; Napoli J; Enver T; Bernardino L; Ferreira L
Nat Commun; 2020 Aug; 11(1):4265. PubMed ID: 32848154
[TBL] [Abstract][Full Text] [Related]
18. Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2-3: A narrative review.
Desravines N; Miele K; Carlson R; Chibwesha C; Rahangdale L
Gynecol Oncol Rep; 2020 Aug; 33():100608. PubMed ID: 32685652
[TBL] [Abstract][Full Text] [Related]
19. Nano-enabled delivery of diverse payloads across complex biological barriers.
Ross KA; Brenza TM; Binnebose AM; Phanse Y; Kanthasamy AG; Gendelman HE; Salem AK; Bartholomay LC; Bellaire BH; Narasimhan B
J Control Release; 2015 Dec; 219():548-559. PubMed ID: 26315817
[TBL] [Abstract][Full Text] [Related]
20. Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines.
Mallapragada SK; Brenza TM; McMillan JM; Narasimhan B; Sakaguchi DS; Sharma AD; Zbarska S; Gendelman HE
Nanomedicine; 2015 Apr; 11(3):715-29. PubMed ID: 25652894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
